Thorndike Anne N, Regan Susan, McKool Kathleen, Pasternak Richard C, Swartz Susan, Torres-Finnerty Nancy, Rigotti Nancy A
Tobacco Research and Treatment Center, General Medical Division, and Cardiology Division, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts 02114, USA.
Arch Intern Med. 2008 Jan 28;168(2):186-91. doi: 10.1001/archinternmed.2007.60.
Although smoking cessation is essential for prevention of secondary cardiovascular disease (CVD), many smokers do not stop smoking after hospitalization. Mild depressive symptoms are common during hospitalization for CVD. We hypothesized that depressive symptoms measured during hospitalization for acute CVD would predict return to smoking after discharge from the hospital.
This was a planned secondary analysis of data from a placebo-controlled, double-blind, randomized trial of bupropion hydrochloride therapy in 245 smokers hospitalized for acute CVD. All subjects received smoking counseling in the hospital and for 12 weeks after discharge. Depressive symptoms were measured during hospitalization with the Beck Depression Inventory (BDI), and smoking cessation was biochemically validated at 2-week, 12-week, and 1-year follow-up. The effect of depressive symptoms on smoking cessation was assessed using multiple logistic regression and survival analyses.
Twenty-two percent of smokers had moderate to severe depressive symptoms (BDI >or= 16) during hospitalization. These smokers were more likely to resume smoking by 4 weeks after discharge (P= .007; incidence rate ratio, 2.40; 95% confidence interval, 1.48-3.78) than were smokers with lower BDI scores. Smokers with low BDI scores were more likely to remain abstinent than were those with high BDI scores at 3-month follow-up (37% vs 15%; adjusted odds ratio, 3.02; 95% confidence interval, 1.28-7.09) and 1-year follow-up (27% vs 10%; adjusted odds ratio, 3.77; 95% confidence interval, 1.31-10.82). We estimate that 27% of the effect of the BDI score on smoking cessation was mediated by nicotine withdrawal symptoms.
Moderate to severe depressive symptoms during hospitalization for acute CVD are independently associated with rapid relapse to smoking after discharge and lower rates of smoking cessation at long-term follow-up. The relationship was mediated in part by the stronger nicotine withdrawal symptoms experienced by smokers with higher depressive symptoms.
尽管戒烟对于预防继发性心血管疾病(CVD)至关重要,但许多吸烟者在住院后并未戒烟。轻度抑郁症状在CVD住院期间很常见。我们假设,急性CVD住院期间测得的抑郁症状可预测出院后复吸情况。
这是一项对245名因急性CVD住院的吸烟者进行的盐酸安非他酮治疗的安慰剂对照、双盲、随机试验数据的计划二次分析。所有受试者在医院接受了吸烟咨询,并在出院后接受了12周的咨询。住院期间用贝克抑郁量表(BDI)测量抑郁症状,并在2周、12周和1年随访时通过生化方法验证戒烟情况。使用多元逻辑回归和生存分析评估抑郁症状对戒烟的影响。
22%的吸烟者在住院期间有中度至重度抑郁症状(BDI≥16)。与BDI得分较低的吸烟者相比,这些吸烟者在出院后4周内更有可能复吸(P = .007;发病率比,2.40;95%置信区间,1.48 - 3.78)。在3个月随访时(37%对15%;调整后的优势比,3.02;95%置信区间,1.28 - 7.09)和1年随访时(27%对10%;调整后的优势比, 3.77;95%置信区间,1.31 - 10.82),BDI得分低的吸烟者比BDI得分高的吸烟者更有可能保持戒烟状态。我们估计BDI得分对戒烟影响的27%是由尼古丁戒断症状介导的。
急性CVD住院期间的中度至重度抑郁症状与出院后迅速复吸以及长期随访时较低的戒烟率独立相关。这种关系部分是由抑郁症状较重的吸烟者经历的更强的尼古丁戒断症状介导的。